High materiality7/10
Regenxbio price target raised to $18 from $16 at Morgan Stanley
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Morgan Stanley raises Regenxbio (RGNX) price target to $18 from $16; current price $10.49.
- Morgan Stanley raises Regenxbio (RGNX) target to $18 from $16; current price $10.49.
Key facts
- 01
Target: $18
- 02
Posted price: $10.49
- 03
Analyst firm: Morgan Stanley
- 04
Analyst: Judah Frommer
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.